Tangoe Retains $28 Price Target and 1 Stock Analysis to Eye
Tangoe Inc (NASDAQ:TNGO): According to Deutsche Bank, Tangoe’s first user conference confirmed that there is strength in the company’s business. The firm believes that the recent pullback in the company’s shares creates a buying opportunity, and it maintains its Buy rating and a $28 price target on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Pacira Pharmaceuticals Inc (NASDAQ:PCRX): Piper Jaffray credits yesterday’s pullback in the company’s shares to confusion about Exparel usage. Piper continues to be confident in its 2012 Exparel sales estimate of $20 million, and it believes that yesterday’s weakness is a buying opportunity. The firm keeps its Overweight rating and a $22 price target on the stock.
Don’t Miss: How Healthy Are UnitedHealth and athenahealth?